Liver-directed stereotactic body radiotherapy can be reliably delivered to selected patients without internal fiducial markers-A case series

J Chin Med Assoc. 2022 Oct 1;85(10):1028-1032. doi: 10.1097/JCMA.0000000000000798. Epub 2022 Aug 24.

Abstract

Tumor motion and the lack of tissue-tumor contrast have been challenging parts of liver-directed stereotactic body radiotherapy (SBRT). In this study, we investigated the possibility of liver-directed SBRT without internal fiducials using breath hold technique and diaphragm matching technique. One hundred thirty-four volumetric images of 13 consecutive patients with either primary or metastatic liver tumors who underwent expiratory breath hold SBRT were compared and analyzed. Reproducibility of diaphragm position between fractions relative to bone was evaluated on image registration software. At median follow-up time of 13 months, 1-year and 2-year local control rates of index lesions were 90% and 72%, respectively. In comparison to diaphragm matching, a greater margin is required for bone matching technique for that 19 of 67 (28%) of all interfractional SI offsets were more than 6 mm, whereas 6 of 67 (9%) intrafractional SI exceeded 6 mm. Despite the small study size, our study showed that breath hold SBRT without internal hepatic fiducial is a valid approach for selected patients.

MeSH terms

  • Fiducial Markers
  • Humans
  • Liver Neoplasms* / radiotherapy
  • Liver Neoplasms* / surgery
  • Radiosurgery* / methods
  • Reproducibility of Results